LIGAND PHARMACEUTICALS INCORPORATED Common Stock ($0.001 par value per share) AT-THE-MARKET EQUITY OFFERING SALES AGREEMENTAt-the-Market Equity Offering Sales Agreement • September 30th, 2022 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledSeptember 30th, 2022 Company Industry Jurisdiction